Title: Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10
Authors: Steidler, L ×
Neirynck, S
Huyghebaert, N
Snoeck, V
Vermeire, A
Goddeeris, Bruno
Cox, E
Remon, JP
Remaut, E #
Issue Date: Jul-2003
Publisher: Nature publishing group
Series Title: Nature biotechnology vol:21 issue:7 pages:785-789
Abstract: Genetically modified Lactococcus lactis secreting interleukin 10 provides a therapeutic approach for inflammatory bowel disease. However, the release of such genetically modified organisms through clinical use raises safety concerns. In an effort to address this problem, we replaced the thymidylate synthase gene thyA of L. lactis with a synthetic human IL10 gene. This thyA - hIL10(+) L. lactis strain produced human IL-10 (hIL-10), and when deprived of thymidine or thymine, its viability dropped by several orders of magnitude, essentially preventing its accumulation in the environment. The biological containment system and the bacterium's capacity to secrete hIL-10 were validated in vivo in pigs. Our approach is a promising one for transgene containment because, in the unlikely event that the engineered L. lactis strain acquired an intact thyA gene from a donor such as L. lactis subsp. cremoris, the transgene would be eliminated from the genome.
ISSN: 1087-0156
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Non-KU Leuven Association publications
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Steidler 2003 Nat Biotech.pdf Published 804KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science